LMAT

108.49

0.24% -0.26

Dopo l'orario di chiusura: 108.49

Lemaitre Vascular Inc (LMAT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Storia dei dividendi

Precedente Chiudi:

$108.75

Aprire:

$108.55

Volume 24 ore:

140.45K

Relative Volume:

0.67

Capitalizzazione di mercato:

$2.47B

Reddito:

$249.60M

Utile/perdita netta:

$57.73M

Rapporto P/E:

43.16

EPS:

2.5139

Flusso di cassa netto:

$74.47M

1 W Prestazione:

-1.67%

1M Prestazione:

+1.02%

6M Prestazione:

+24.89%

1 anno Prestazione:

+25.25%

Intervallo 1D:

$105.50

$109.41

Intervallo di 1 settimana:

$104.14

$110.45

Portata 52W:

$71.42

$115.33

Lemaitre Vascular Inc Stock (LMAT) Company Profile

Nome

Lemaitre Vascular Inc

Settore

Healthcare (1118)

Industria

Medical Instruments & Supplies (58)

Telefono

781-221-2266

Indirizzo

63 SECOND AVENUE, BURLINGTON, MA

Dipendente

655

Cinguettio

@LMAT_Vascular

Prossima data di guadagno

2025-02-24

Ultimi documenti SEC

LMAT's Discussions on Twitter

Compare LMAT vs ISRG, BDX, ALC, MDLN, RMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LMAT Lemaitre Vascular Inc	108.49	2.47B	249.60M	57.73M	74.47M	2.5139
ISRG Intuitive Surgical Inc	452.07	160.56B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	154.51	43.95B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	74.56	36.34B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	44.28	35.94B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	224.09	32.65B	5.40B	1.49B	1.78B	10.12

Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-08-06	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2025-02-28	Downgrade	Barrington Research	Outperform → Mkt Perform
2025-02-28	Downgrade	Oppenheimer	Outperform → Perform
2025-02-13	Iniziato	Wells Fargo	Equal Weight
2024-10-15	Iniziato	Cantor Fitzgerald	Neutral
2024-08-02	Ripresa	Lake Street	Buy
2024-05-31	Ripresa	ROTH MKM	Buy
2024-04-26	Aggiornamento	Stifel	Hold → Buy
2024-02-06	Ripresa	KeyBanc Capital Markets	Sector Weight
2023-10-23	Iniziato	JMP Securities	Mkt Outperform
2023-09-06	Iniziato	Oppenheimer	Outperform
2023-08-03	Downgrade	Jefferies	Buy → Hold
2023-05-03	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2022-10-28	Downgrade	Barrington Research	Outperform → Mkt Perform
2021-09-16	Iniziato	Jefferies	Buy
2021-02-12	Iniziato	KeyBanc Capital Markets	Sector Weight
2020-03-16	Aggiornamento	Sidoti	Neutral → Buy
2019-10-24	Downgrade	First Analysis Sec	Strong Buy → Outperform
2019-10-24	Aggiornamento	Lake Street	Hold → Buy
2019-10-14	Aggiornamento	First Analysis Sec	Outperform → Strong Buy
2019-07-25	Reiterato	Barrington Research	Outperform
2019-07-25	Aggiornamento	First Analysis Sec	Neutral → Outperform
2018-10-08	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2018-10-08	Aggiornamento	ROTH Capital	Neutral → Buy
2018-06-08	Ripresa	ROTH Capital	Buy
2018-04-26	Downgrade	Stifel	Buy → Hold
2018-04-26	Aggiornamento	The Benchmark Company	Hold → Buy
2017-10-27	Downgrade	First Analysis Sec	Overweight → Equal-Weight
2017-10-27	Downgrade	The Benchmark Company	Buy → Hold
2017-07-10	Downgrade	Canaccord Genuity	Buy → Hold
2017-07-10	Downgrade	The Benchmark Company	Buy → Hold
2017-03-21	Iniziato	First Analysis Sec	Overweight
2017-02-22	Downgrade	Barrington Research	Outperform → Mkt Perform
2016-09-22	Downgrade	Sidoti	Buy → Neutral
2016-07-28	Reiterato	Barrington Research	Outperform
2016-02-25	Reiterato	Barrington Research	Outperform

Mostra tutto

Lemaitre Vascular Inc Borsa (LMAT) Ultime notizie

Apr 04, 2026

LMAT Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai

Apr 04, 2026

Apr 02, 2026

LMAT SEC FilingsLemaitre Vasculr 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 02, 2026

LeMaitre Vascular (NASDAQ:LMAT) Upgraded at Freedom Capital - MarketBeat

Apr 02, 2026

SG Americas Securities LLC Raises Stock Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat

Apr 02, 2026

Is LeMaitre Vascular, Inc. (LMAT) a good stock to buy now? - MSN

Apr 02, 2026

LMAT Stock Price, Quote & Chart | LEMAITRE VASCULAR INC (NASDAQ:LMAT) - ChartMill

Apr 02, 2026

Mar 31, 2026

Gainers Report: Is LeMaitre Vascular Inc a strong candidate for buy and hold2026 EndofMonth & Weekly High Return Stock Forecasts - baoquankhu1.vn

Mar 31, 2026

LeMaitre (NASDAQ: LMAT) director receives dividend equivalent rights awards - Stock Titan

Mar 30, 2026

Dividend equivalents boost LeMaitre Vascular (LMAT) director stock awards - Stock Titan

Mar 30, 2026

LeMaitre Vascular (LMAT) director granted new dividend equivalent rights - Stock Titan

Mar 30, 2026

LeMaitre (NASDAQ: LMAT) director awarded new dividend equivalent rights - Stock Titan

Mar 30, 2026

LeMaitre (NASDAQ: LMAT) director awarded dividend equivalent rights - Stock Titan

Mar 30, 2026

LeMaitre Vascular (LMAT) president reports grants of dividend equivalent rights - Stock Titan

Mar 30, 2026

LeMaitre (LMAT) SVP awarded new dividend equivalent rights grants - Stock Titan

Mar 30, 2026

LeMaitre Vascular (LMAT) CFO granted new dividend equivalent rights - Stock Titan

Mar 30, 2026

LeMaitre Vascular (NASDAQ: LMAT) CEO receives dividend equivalent rights grants - Stock Titan

Mar 30, 2026

Mar 29, 2026

Why The LeMaitre Vascular (LMAT) Story Is Evolving As Targets Cluster Around US$111 - finance.yahoo.com

Mar 29, 2026

Is LeMaitre Vascular, Inc. (LMAT) A Good Stock To Buy Now? - insidermonkey.com

Mar 29, 2026

JPMorgan Chase & Co. Has $10.68 Million Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat

Mar 29, 2026

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Mar 29, 2026

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Mar 29, 2026

Mar 28, 2026

LeMaitre Vascular Executive Stock SaleMarch 2026 UpdateNews and Statistics - IndexBox

Mar 28, 2026